ライフサイエンスコーパス: guanosine monophosphate

1 rease intracellular concentrations of cyclic guanosine monophosphate.

2 stiff because of low nitric oxide and cyclic guanosine monophosphate.

3 a bacterial riboswitch that binds cyclic-di-guanosine monophosphate.

4 he Watson-Crick complementary nucleotide, 5'-guanosine monophosphate (5'-GMP), was seen in the case o

5 methyl ester (L-NAME), 8-bromo-cyclic 3',5'-guanosine monophosphate (8-bromo-cGMP), and nitroglyceri

6 e monophosphate [8br-cAMP] and 8bromo cyclic guanosine monophosphate [8br-cGMP]) in rat liver preserv

7 omo-cyclic AMP (8BrcAMP), and 8-bromo-cyclic guanosine monophosphate (8BrcGMP) also inhibited the glu

8 of sGCalpha1 is independent of NO and cyclic guanosine monophosphate, a major mediator of the sGC enz

9 Urinary excretion of cyclic guanosine monophosphate, a marker for renal NO productio

10 Tissue 3',5'-cyclic guanosine monophosphate, a potent vasodilator, was great

11 al and bradykinin-stimulated cellular cyclic guanosine monophosphate accumulation and L-citrulline co

12 nce or absence of 7-nitroindazole and cyclic guanosine monophosphate accumulation was determined.

13 mined in vitro in cardiac fibroblasts cyclic guanosine monophosphate-activating and antiproliferative

14 The DNA sensor cyclic guanosine monophosphate-adenosine monophosphate (cGAMP)

15 e show that M. tuberculosis activated cyclic guanosine monophosphate-adenosine monophosphate (cGAMP)

16 we show that HIV infection activates cyclic guanosine monophosphate-adenosine monophosphate (cGAMP)

17 proaches led to the identification of cyclic guanosine monophosphate-adenosine monophosphate (cGAMP)

18 or of interferon genes (STING), 2'3'- cyclic guanosine monophosphate-adenosine monophosphate (cGAMP),

19 With the STING ligand cyclic guanosine monophosphate-adenosine monophosphate (cGAMP),

20 interferons through the production of cyclic guanosine monophosphate-adenosine monophosphate (cyclic

21 malian cytosolic extracts synthesized cyclic guanosine monophosphate-adenosine monophosphate (cyclic

22 a pathway dependent on the DNA sensor cyclic guanosine monophosphate-adenosine monophosphate synthase

23 V infection and mice lacking STING or cyclic guanosine monophosphate-adenosine monophosphate synthase

24 Cyclic guanosine monophosphate-adenosine monophosphate synthase

25 Guanosine monophosphate, among the nucleotides, has the

26 s, and these effects were mimicked by cyclic guanosine monophosphate analogs.

27 owing mRNA degradation, releasing N-7 methyl guanosine monophosphate and 5'-diphosphate terminated ca

28 In addition, CD-NP in vitro activates cyclic guanosine monophosphate and inhibits cardiac fibroblast

29 of cyclic adenosine monophosphate and cyclic guanosine monophosphate and is highly expressed in mediu

30 synthase (NOS) activity and decreased cyclic guanosine monophosphate and nitrite production.

31 admixture was calculated, and plasma cyclic guanosine monophosphate and sildenafil concentrations we

32 iated with elevation of intraplatelet cyclic guanosine monophosphate and was reversed by the nitric o

33 xide-dependent signaling (via sGC and cyclic guanosine monophosphate) and nitric oxide-independent si

34 of cyclic adenosine monophosphate and cyclic guanosine monophosphate, and, consequently, exhibit a ce

35 n vascular endothelial growth factor, cyclic guanosine monophosphate, angiogenesis, endogenous cell p

36 i indicates that NO signaling through cyclic guanosine monophosphate arose before the origin of multi

37 ieved using a reversible biogel formed by 5'-guanosine monophosphate as the run buffer in capillary e

38 e significantly increases cortical levels of guanosine monophosphate both in ischemic and nonischemic

39 second messenger bis-(3'-5')-cyclic-dimeric-guanosine monophosphate (c-di-GMP) acts as an innate imm

40 ane protein whose bis-(3',5')-cyclic dimeric guanosine monophosphate (c-di-GMP) binding activity post

41 eased intracellular levels of cyclic dimeric guanosine monophosphate (c-di-GMP) compared to that of a

42 ignaling molecule bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) controls important bi

43 second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) controls secretion, c

44 that catalyze formation of cyclic di-(3',5')-guanosine monophosphate (c-di-GMP) from GTP.

45 Bis-(3',5')-cyclic-dimeric-guanosine monophosphate (c-di-GMP) has been shown to be

46 a higher level of bis(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) in cells respiring on

47 Cyclic dimeric guanosine monophosphate (c-di-GMP) is a common, bacteria

48 Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) is a dynamic intracel

49 e bacterial second messenger cyclic di-3',5'-guanosine monophosphate (c-di-GMP) is a key regulator of

50 Cyclic di-(3':5')-guanosine monophosphate (c-di-GMP) is a major prokaryote

51 The cyclic dinucleotide cyclic-di-guanosine monophosphate (c-di-GMP) is a recently appreci

52 ly controls the intracellular cyclic dimeric guanosine monophosphate (c-di-GMP) level through a recep

53 Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) modulates the transit

54 second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) plays a vital role in

55 The bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) signaling pathway reg

56 activity towards bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP), but does not show di

57 erial secondary messenger, cyclic di-(3',5')-guanosine monophosphate (c-di-GMP), represents a balance

58 f the prokaryotic second messenger cyclic di-guanosine monophosphate (c-di-GMP), yet the signaling me

59 second messenger--bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP)--that perceives and t

60 osphodiesterase whose substrate is cyclic di-guanosine monophosphate (c-di-GMP)-a bacterial second me

61 llular quadruplexes formed by cyclic dimeric guanosine monophosphate (c-di-GMP).

62 concentrations of cyclic 3',5'-adenosine and guanosine monophosphates (cAMP and cGMP, respectively) b

63 ation in vitro by preventing platelet cyclic guanosine monophosphate catabolism.

64 potensive mediators, nitric oxide and cyclic guanosine monophosphate, cause these phenotypes.

65 bacterial second messenger (3'-5')-cyclic-di-guanosine-monophosphate (CDG) is a promising mucosal adj

66 In vitro 3',5'-cyclic guanosine monophosphate (cGMP) activation in response to

67 Sildenafil and an analog of cyclic guanosine monophosphate (cGMP) also induced capillary-li

68 aBalpha accumulation; and b) a stable cyclic guanosine monophosphate (cGMP) analog (8-bromo-cGMP) to

69 3B (PDE3B), and a membrane-permeable cyclic guanosine monophosphate (cGMP) analog on KATP channel ac

70 onary circulation, the roles of cyclic 3'-5'-guanosine monophosphate (cGMP) and cGMP-phosphodiesteras

71 phosphodiesterase (PDE V) metabolizes cyclic guanosine monophosphate (cGMP) and is abundant in the ki

72 In healthy control subjects, urinary cyclic guanosine monophosphate (cGMP) and natriuresis increased

73 ) and significantly smaller levels of cyclic guanosine monophosphate (cGMP) and peroxisome proliferat

74 5 (PDE5) catalytic-site affinity for cyclic guanosine monophosphate (cGMP) and potency of inhibitors

75 se type 5 (PDE5) acts specifically on cyclic guanosine monophosphate (cGMP) and terminates cGMP-media

76 s study we tested the hypothesis that cyclic guanosine monophosphate (cGMP) and the dependent protein

77 c guanosine monophosphate (RpcGMP), a cyclic guanosine monophosphate (cGMP) antagonist, attenuated th

78 G protein-coupled receptors and cyclic guanosine monophosphate (cGMP) are implicated in the res

79 ic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) are now recognized as imp

80 d evidence that nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) are signaling intermediat

81 tion by using immunocytochemistry for cyclic guanosine monophosphate (cGMP) as an indicator.

82 ic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) as well as calcium and pH

83 Production of cyclic guanosine monophosphate (cGMP) by guanylate cyclase is o

84 ry vasodilation through activation of cyclic guanosine monophosphate (cGMP) by way of particulate gua

85 nce may, in part, relate to increased cyclic guanosine monophosphate (cGMP) catabolism by PDE5.

86 NO production, as estimated by aortic cyclic guanosine monophosphate (cGMP) concentration and endothe

87 and serum nitrite/ nitrate and atrial cyclic guanosine monophosphate (cGMP) concentrations were assay

88 Cyclic guanosine monophosphate (cGMP) content in the chamber ti

89 ic oxide synthase (NOS) activity, and cyclic guanosine monophosphate (cGMP) content were also assesse

90 Moreover, relaxation was cyclic guanosine monophosphate (cGMP) dependent and was inhibit

91 pothesized that nitric oxide promotes cyclic guanosine monophosphate (cGMP) formation, which, in turn

92 stimulates production and release of cyclic guanosine monophosphate (cGMP) from intestinal epithelia

93 The conclusion that cyclic 3'-5 guanosine monophosphate (cGMP) functions in a 'permissiv

94 ciated with a significant decrease in cyclic guanosine monophosphate (cGMP) generation after S-nitros

95 by increases in intracellular cyclic 3', 5'-guanosine monophosphate (cGMP) in a small network of 50

96 tion of NO, as estimated by measuring cyclic guanosine monophosphate (cGMP) in aortic tissue in two m

97 e (BNP) on cellular proliferation and cyclic guanosine monophosphate (cGMP) in human aortic vascular

98 2A)) receptors increase production of cyclic guanosine monophosphate (cGMP) in slices of rat frontal

99 lices obtained from endotoxemic mice, cyclic guanosine monophosphate (cGMP) increased significantly a

100 trite and nitrate accumulation and by cyclic guanosine monophosphate (cGMP) increases in rat reporter

101 3',5'-cyclic guanosine monophosphate (cGMP) is a common second messen

102 Cyclic guanosine monophosphate (cGMP) is a key secondary messen

103 Cyclic guanosine monophosphate (cGMP) is a second messenger mol

104 Cyclic guanosine monophosphate (cGMP) is an important intracell

105 3',5'-Cyclic guanosine monophosphate (cGMP) is an important second me

106 The intracellular nucleotide cyclic guanosine monophosphate (cGMP) is found in many human or

107 Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) leading to increased leve

108 and 28 days (n = 3) and evaluated for cyclic guanosine monophosphate (cGMP) levels (7 days), number o

109 th a short half-life, increases brain cyclic guanosine monophosphate (cGMP) levels and improves neuro

110 nger RNA (mRNA), protein, nitrite and cyclic guanosine monophosphate (cGMP) levels in Kupffer cells.

111 Cyclic 3',5'-guanosine monophosphate (cGMP) levels in the brainstem w

112 minute reperfusion cycles, myocardial cyclic guanosine monophosphate (cGMP) levels increased signific

113 Vascular cyclic guanosine monophosphate (cGMP) levels were elevated afte

114 ith and without SNP did not affect EC cyclic guanosine monophosphate (cGMP) levels, and the cGMP anal

115 osphorylation and activity as well as cyclic guanosine monophosphate (cGMP) levels, with all of these

116 guanylyl cyclase and, thus, enhances cyclic guanosine monophosphate (cGMP) levels.

117 Elevated intracellular levels of cyclic guanosine monophosphate (cGMP) may induce apoptosis, and

118 attributable to hyporesponsiveness of cyclic guanosine monophosphate (cGMP) mediated vasorelaxation e

119 In the vertebrate retina, cyclic guanosine monophosphate (cGMP) mediates photoreceptor si

120 ic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) often mediate antagonisti

121 producing the intracellular messenger cyclic guanosine monophosphate (cGMP) on activation with nitric

122 es the kinase independently of the NO-cyclic guanosine monophosphate (cGMP) pathway and is coupled to

123 , the diatomic gas is critical to the cyclic guanosine monophosphate (cGMP) pathway as it functions a

124 ion of the atrial natriuretic peptide-cyclic guanosine monophosphate (cGMP) pathway in cardiac electr

125 A key component of the nitric oxide-cyclic guanosine monophosphate (cGMP) pathway in smooth muscle

126 ates a soluble guanylyl cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway in the behavioral

127 or tone and platelet activity via the cyclic guanosine monophosphate (cGMP) pathway, but whether coro

128 n of intracellular Ca2+ ([Ca2+]i) and cyclic guanosine monophosphate (cGMP) production (index of nitr

129 tudy was to determine whether hepatic cyclic guanosine monophosphate (cGMP) reduces NHGU.

130 provide evidence for a novel role of cyclic guanosine monophosphate (cGMP) signaling in the regulati

131 ne monophosphate (cAMP) and augmented cyclic guanosine monophosphate (cGMP) signaling is characterist

132 The cyclic guanosine monophosphate (cGMP) specific phosphodiesteras

133 Cyclic guanosine monophosphate (cGMP) stimulated human phosphod

134 urement of [Ca (2+)] i in response to cyclic guanosine monophosphate (cGMP) stimulation.

135 t on and independent of modulation of cyclic guanosine monophosphate (cGMP) subsequent to activation

136 Assays of cyclic guanosine monophosphate (cGMP) synthesis from guanosine

137 as increased 11-fold and the K(i) for cyclic guanosine monophosphate (cGMP) was 27-fold higher than P

138 Cyclic guanosine monophosphate (cGMP) was measured by enzyme im

139 tigated whether nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) were involved in memory c

140 xide (NO), catalyzes the formation of cyclic guanosine monophosphate (cGMP), an intracellular second

141 xpression and levels of nitric oxide, cyclic guanosine monophosphate (cGMP), and nitrotyrosine.

142 l methods to study the effects of NO, cyclic guanosine monophosphate (cGMP), and peroxynitrite on the

143 nctions through its second messenger, cyclic guanosine monophosphate (cGMP), and protein kinase G (PK

144 soluble guanosine cyclase to produce cyclic guanosine monophosphate (cGMP), and we observed that EPO

145 itric oxide pathway effector molecule cyclic guanosine monophosphate (cGMP), has been implicated in t

146 Cyclic guanosine monophosphate (cGMP), however, has been given

147 The second messenger, cyclic guanosine monophosphate (cGMP), mediates the actions of

148 ated events, such as the induction of cyclic guanosine monophosphate (cGMP), NADPH diaphorase activit

149 diameter, and its upstream control by cyclic guanosine monophosphate (cGMP), nitrosative/oxidative st

150 hibitors and activators of sGC, 3',5'-cyclic guanosine monophosphate (cGMP), protein kinase G (PKG),

151 duces plexus neurons to produce cyclic 3',5' guanosine monophosphate (cGMP), suggesting the presence

152 in follicular somatic cells, produces cyclic guanosine monophosphate (cGMP), which maintains meiotic

153 t, VWF did not promote an increase in cyclic guanosine monophosphate (cGMP), while agents that elevat

154 ownstream target of sildenafil in the cyclic guanosine monophosphate (cGMP)-activated protein kinase

155 el from Caenorhabditis elegans in the cyclic guanosine monophosphate (cGMP)-bound open state.

156 ds on NOS2 activity and the canonical cyclic guanosine monophosphate (cGMP)-cGMP-dependent protein ki

157 The gene Prkg2, encoding cyclic guanosine monophosphate (cGMP)-dependent protein kinase

158 Cyclic guanosine monophosphate (cGMP)-dependent protein kinase

159 nts are phosphorylated transiently by cyclic guanosine monophosphate (cGMP)-dependent protein kinase

160 is the foraging gene, which encodes a cyclic guanosine monophosphate (cGMP)-dependent protein kinase

161 signalling paradigm, we show that the cyclic guanosine monophosphate (cGMP)-dependent protein kinase,

162 reas the response to ascr#3 relies on cyclic guanosine monophosphate (cGMP)-gated channels and activi

163 tions in genes encoding subunits of a cyclic guanosine monophosphate (cGMP)-gated ion channel (tax-4

164 ndothelium-dependent and -independent cyclic guanosine monophosphate (cGMP)-mediated vasodilation in

165 a depolarizing conductance carried by cyclic guanosine monophosphate (cGMP)-sensitive cyclic nucleoti

166 ukocyte Mac-1-integrin activation and cyclic guanosine monophosphate (cGMP)-signaling, leading to red

167 converts guanosine-5'-triphosphate to cyclic guanosine monophosphate (cGMP).

168 lyl-cyclase, GCY-8, which synthesizes cyclic guanosine monophosphate (cGMP).

169 asing intracellular concentrations of cyclic guanosine monophosphate (cGMP).

170 label positively with an antibody to cyclic guanosine monophosphate (cGMP).

171 at recognize elevated levels of cyclic 3;,5;-guanosine monophosphate (cGMP).

172 ric oxide (NO) and increase levels of cyclic guanosine monophosphate (cGMP).

173 creasing pulmonary vascular levels of cyclic guanosine monophosphate (cGMP).

174 ic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).

175 on of calcium influx into the cell by cyclic guanosine monophosphate (cGMP).

176 uscle to the relaxant effects of 8-Br-cyclic guanosine monophosphate (cGMP).

177 d in markedly increased production of cyclic guanosine monophosphate (cGMP).

178 ferative effect is mediated via an NO/cyclic guanosine monophosphate (cGMP)/cGMP-dependent protein ki

179 r PDE activity in platelets is PDE3A (cyclic guanosine monophosphate [cGMP]-inhibited PDE).

180 ble guanylyl cyclase (which generates cyclic guanosine monophosphate, cGMP) was the first identified

181 By using immunohistochemistry against cyclic guanosine monophosphate, cochlear sGC activity was local

182 inorganic nitrate-nitrite, myocardial cyclic guanosine monophosphate content by neprilysin or phospho

183 reduces nitric oxide bioavailability, cyclic guanosine monophosphate content, and protein kinase G (P

184 genes putatively involved in cyclic-dimeric guanosine monophosphate (cyclic-di-GMP) metabolism.

185 -cGMP) and N(2),2'-o-dibutyryl 3', 5'-cyclic guanosine monophosphate (dB-cGMP), and of the selective

186 endogenous peptide ligands initiates cyclic guanosine monophosphate-dependent (cGMP) salt and water

187 cycle progression, which include both cyclic guanosine monophosphate-dependent and -independent pathw

188 teins involved in the mating process, cyclic guanosine monophosphate-dependent kinase, and the cation

189 vessels from endotoxemic animals in a cyclic guanosine monophosphate-dependent manner, suggesting tha

190 The arrest was downstream of cyclic guanosine monophosphate-dependent protein kinase (PfPKG)

191 either guanylyl cyclase A receptor or cyclic guanosine monophosphate-dependent protein kinase in cult

192 lar signal-related kinase pathway via cyclic guanosine monophosphate-dependent protein kinase signali

193 Cyclic di-guanosine monophosphate (di-GMP) is a circular RNA dinuc

194 sis associated with increased urinary cyclic guanosine monophosphate excretion (UcGMPV), glomerular f

195 the formation of 3', 5'-cyclic adenosine or guanosine monophosphate from the corresponding nucleosid

196 ose media was paralleled by decreased cyclic guanosine monophosphate generation; however, there was n

197 nhibition of 3'-->5' exonuclease activity by guanosine monophosphate (GMP) abolished the ability of p

198 osphate (XMP), the committed step in de novo guanosine monophosphate (GMP) biosynthesis.

199 phate (PRPP) binding to the enzyme first and guanosine monophosphate (GMP) dissociating last.

200 uple biotin to a 'caged' photocleavable (PC) guanosine monophosphate (GMP) in high yield.

201 In dilute 5'-guanosine monophosphate (GMP) solutions, G-quartets form

202 genetic approach in zebrafish, we found that guanosine monophosphate (GMP) synthetase mutant larvae d

203 catalyze the breakdown of cAMP and/or cyclic guanosine monophosphate (GMP) to their inactive form.

204 creased in parallel with a decline in cyclic guanosine monophosphate (GMP).

205 petitive substrate for ecto-5'-nucleotidase (guanosine monophosphate, GMP) did not affect basal VP re

206 Most cyclic guanosine monophosphate hydrolysis (about 80%) in cultur

207 Sildenafil is a potent inhibitor of cyclic guanosine monophosphate hydrolysis [corrected] in the co

208 Type 5 is the main factor regulating cyclic guanosine monophosphate hydrolysis and downstream signal

209 ogenous NO also was examined by using cyclic guanosine monophosphate immunocytochemistry.

210 ficity cyclic adenosine monophosphate/cyclic guanosine monophosphate-inhibiting enzyme.

211 a greater elevation of intracellular cyclic guanosine monophosphate levels compared with nitric oxid

212 ricles from Cav-3 OE mice had greater cyclic guanosine monophosphate levels, less nuclear factor of a

213 Neither cyclic guanosine monophosphate nor guanylate cyclase were invol

214 Adenosine, uridine, and guanosine monophosphate nucleotides have approximately e

215 thesis can be stimulated by the inclusion of guanosine monophosphate or specific oligoribonucleotides

216 NO-stimulated platelet generation of cyclic guanosine monophosphate (p < 0.02) but not with changes

217 the ability to activate plasma 3',5'-cyclic guanosine monophosphate (p < 0.05 vs. placebo).

218 zed ex vivo by augmentation of the NO-cyclic guanosine monophosphate pathway without normalization of

219 Mechanisms of action of nitric oxide/cyclic guanosine monophosphate/PDE5 pathway in the treatment of

220 llele of the gamma subunit of retinal cyclic guanosine monophosphate phosphodiesterase (PDE gamma) su

221 oward the effector of transducin, the cyclic guanosine monophosphate phosphodiesterase.

222 site mutation in intron 2 of the rod cyclic guanosine monophosphate-phosphodiesterase (cGMP) beta-su

223 ceptor-specific expression of the rod cyclic guanosine monophosphate-phosphodiesterase beta-subunit (

224 racellular matrix remodeling via PDE5/cyclic guanosine monophosphate-PKG regulatory pathways.

225 of Mg2+ concentration and the 2' OH group of guanosine monophosphate, prG, substrate on various steps

226 RO-25-6760, increased NPR-A-dependent cyclic guanosine monophosphate production and NPR-A gene expres

227 in reporter cells resulted in higher cyclic guanosine monophosphate production compared with the wil

228 lable BNP assays and cell activity by cyclic guanosine monophosphate production in vascular cells.

229 ic oxide synthase 1 blockade inhibits cyclic guanosine monophosphate production; 3) pharmacological b

230 x pathways that involve nitric oxide, cyclic guanosine monophosphate, protein kinase G, extracellular

231 Plasma BNP and 3',5'-cyclic guanosine monophosphate rapidly increased and peaked at

232 One of these encodes rat guanosine monophosphate reductase (GMP-r).

233 We further demonstrate that the gene for guanosine monophosphate reductase (GMPR) is a direct MIT

234 f At IMPDH conforms to the IMP dehydrogenase/guanosine monophosphate reductase motif and contains an

235 as the mRNA levels of uncoupling protein 1, guanosine monophosphate reductase, and peroxisome prolif

236 xide synthase inhibitor, and Rp-8 CPT-cyclic guanosine monophosphate (RpcGMP), a cyclic guanosine mon

237 -targeted regulation of cardiomyocyte cyclic guanosine monophosphate-selective phosphodiesterase type

238 neurons, which utilize diverse cyclic 3',5'-guanosine monophosphate signaling pathways and could ser

239 Sildenafil (SIL) inhibits cyclic guanosine monophosphate-specific PDE5A and can blunt the

240 bosyl pyrophosphate (PRPP) amidotransferase, guanosine monophosphate synthetase (GMPS) will not utili

241 Guanosine monophosphate synthetase is essential for de n

242 te cyclase and a higher production of cyclic guanosine monophosphate that together may help explain s

243 ssenger c-di-GMP (Bis-(3'-5')-cyclic dimeric guanosine monophosphate), to make a vital choice: whethe

244 anylate cyclase domains that mobilize cyclic guanosine monophosphate upon binding of peptide.

245 The levels of nitric oxide and cyclic guanosine monophosphate were also significantly reduced

246 , Na2 [(HGMP)2 Mo5 O15 ]7 H2 O (1; where GMP=guanosine monophosphate), which spontaneously assembles

247 ide-dependent excretion of sodium and cyclic guanosine monophosphate without affecting mean arterial